JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area mapk pka'

Search results for: 'research area mapk pka'

A8245 Sorafenib Tosylate

1 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥31.85 mg/mL
A3009 Sorafenib

2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
A8687 VX-702

Summary: P38α MAPK inhibitor,highly selective and ATP-competitive

insoluble in H2O; ≥20.2 mg/mL
B4620 Losmapimod

1 Citation

Summary: p38 MAPK inhibitor, orally active

insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL
A8689 PD 169316

Target: p38

Summary: P38 MAPK inhibitor

insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
B1285 SB 203580 hydrochloride

Target: p38

Summary: Specific p38-MAPKs inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
A3199 AT7867 dihydrochloride

Summary: Akt1 and p70S6K/PKA inhibitor

Soluble in DMSO
B1150 NSI-189

Summary: Nootropic and neurogenic research chemical

Soluble in DMSO
B7791 6-Bnz-cAMP sodium salt

Summary: cAMP analog,PKA activator

Soluble in H2O
A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL